AGNC vs GLPI

AGNC exhibits severe financial health concerns, as evidenced by a Piotroski F-Score of 3/9 (indicating weak fundamentals) and a missing Altman Z-Score, which raises unquantified distress risk. Despite a high intrinsic value estimate of $43.37 and a Graham Number of $17.64, the stock trades at $10.23, suggesting a potential undervaluation—however, this is undermined by extreme leverage (Debt/Equity: 6.89), near-zero liquidity (Current Ratio: 0.18), and a 97.96% payout ratio. The recent insider selling of $11.43M over six months signals strong bearish sentiment, while earnings have consistently missed expectations in the last four quarters. The 52-week range of $7.85–$12.19 reflects high volatility and lack of sustained momentum.

GLPI presents a stable but conflicted profile, anchored by a Piotroski F-Score of 4/9 indicating stable financial health. While the stock trades at a significant discount to its growth-based intrinsic value ($87.62) and maintains exceptional operating margins (89.28%), it is weighed down by a critical dividend payout ratio of 105.08%. Bearish insider activity and a 0/100 technical trend suggest short-term headwinds despite a 'Buy' analyst consensus and a reasonable P/E ratio relative to the sector.